Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic …
…, RM Habimana, A Rucogoza, LF Moriarty… - The Lancet Infectious …, 2021 - thelancet.com
Background Partial artemisinin resistance is suspected if delayed parasite clearance (ie,
persistence of parasitaemia on day 3 after treatment initiation) is observed. Validated markers …
persistence of parasitaemia on day 3 after treatment initiation) is observed. Validated markers …
[HTML][HTML] Public health responses to COVID-19 outbreaks on cruise ships—worldwide, February–March 2020
LF Moriarty - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
More than 800 cases of laboratory-confirmed COVID-19 cases occurred during outbreaks
on three cruise ship voyages, and cases linked to several additional cruises have been …
on three cruise ship voyages, and cases linked to several additional cruises have been …
Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso …
A Gansané, LF Moriarty, D Ménard, I Yerbanga… - Malaria Journal, 2021 - Springer
Background The World Health Organization recommends regularly assessing the efficacy of
artemisinin-based combination therapy (ACT), which is a critical tool in the fight against …
artemisinin-based combination therapy (ACT), which is a critical tool in the fight against …
Coronavirus Disease 2019 (COVID-19) in Americans Aboard the Diamond Princess Cruise Ship
…, A Stewart, RL Wagner, LF Moriarty… - Clinical Infectious …, 2021 - academic.oup.com
Background The Diamond Princess cruise ship was the site of a large outbreak of coronavirus
disease 2019 (COVID-19). Of 437 Americans and their travel companions on the ship, …
disease 2019 (COVID-19). Of 437 Americans and their travel companions on the ship, …
[HTML][HTML] Therapeutic efficacy of artemisinin-based combination therapies in Democratic Republic of the Congo and investigation of molecular markers of antimalarial …
LF Moriarty, PM Nkoli, JL Likwela… - The American Journal …, 2021 - ncbi.nlm.nih.gov
Routine assessment of the efficacy of artemisinin-based combination therapies (ACTs) is
critical for the early detection of antimalarial resistance. We evaluated the efficacy of ACTs …
critical for the early detection of antimalarial resistance. We evaluated the efficacy of ACTs …
Early detection of severe acute respiratory syndrome coronavirus 2 variants using traveler-based genomic surveillance at 4 US airports, September 2021–January …
…, AM Plocik, BB Simen, L Moriarty… - Clinical Infectious …, 2023 - academic.oup.com
We enrolled arriving international air travelers in a severe acute respiratory syndrome
coronavirus 2 genomic surveillance program. We used molecular testing of pooled nasal swabs …
coronavirus 2 genomic surveillance program. We used molecular testing of pooled nasal swabs …
Infants and the seasonal influenza vaccine: a global perspective on safety, effectiveness, and alternate forms of protection
LF Moriarty, SB Omer - Human vaccines & immunotherapeutics, 2014 - Taylor & Francis
Seasonal influenza is a substantial cause of severe illness among infants under 6 months of
age globally. There are multiple methods of vaccination against influenza, including …
age globally. There are multiple methods of vaccination against influenza, including …
Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports, September 2021-January 2022
…, B Cosca, G Woronoff, AM Plocik, BB Simen, L Moriarty… - medRxiv, 2022 - medrxiv.org
We enrolled arriving international air travelers in SARS-CoV-2 genomic surveillance, using
molecular testing of pooled nasal swabs, and sequencing positive samples for viral lineage. …
molecular testing of pooled nasal swabs, and sequencing positive samples for viral lineage. …
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and …
…, H Teka, D Dilu, M Haile, H Solomon, LF Moriarty… - Malaria Journal, 2022 - Springer
Background Routine monitoring of anti-malarial drugs is recommended for early detection
of drug resistance and to inform national malaria treatment guidelines. In Ethiopia, the …
of drug resistance and to inform national malaria treatment guidelines. In Ethiopia, the …
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence …
…, G Sebikaari, K Belay, M Niang, ES Halsey, LF Moriarty… - Malaria Journal, 2021 - Springer
Background In Uganda, artemether-lumefantrine (AL) is first-line therapy and
dihydroartemisinin-piperaquine (DP) second-line therapy for the treatment of uncomplicated malaria. …
dihydroartemisinin-piperaquine (DP) second-line therapy for the treatment of uncomplicated malaria. …
